Study Aims to Identify Women with Ovarian Cancer Who May Benefit from Maintenance Treatment
News
Myriad Genetics and AstraZeneca have expanded their collaboration to conduct a study to identify women with advanced ovarian cancer who may benefit from maintenance treatment with Lynparza (olaparib) and Avastin ... Read more